Form 4 filed by Savitz Ryan
Savitz Ryan filed this Form 4 on DNTH (Dianthus Therapeutics, Inc. /DE/) with 29 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-12 22:32:24 UTC.
- Accession
- 0001992324-26-000010
- Filer
- CIK 1992324
- Filed
- 2026-11-12
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: DNTH · Dianthus Therapeutics, Inc. /DE/ (CIK 1690585)
- Savitz Ryan officer (EVP, CFO & CBO)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-09 | M exercised | +29,276 | $17.88 | 29,276 | D |
| Common Stock | 2026-11-09 | M exercised | +20,608 | $21.77 | 49,884 | D |
| Common Stock | 2026-11-09 | M exercised | +40,430 | $22.07 | 90,314 | D |
| Common Stock | 2026-11-09 | M exercised | +10,399 | $8.44 | 100,713 | D |
| Common Stock | 2026-11-09 | S sold | -300 | $85.16 | 100,413 | D |
| Common Stock | 2026-11-09 | S sold | -700 | $86.7 | 99,713 | D |
| Common Stock | 2026-11-09 | S sold | -1,736 | $88.84 | 97,977 | D |
| Common Stock | 2026-11-09 | S sold | -37,517 | $90.12 | 60,460 | D |
| Common Stock | 2026-11-09 | S sold | -58,396 | $90.9 | 2,064 | D |
| Common Stock | 2026-11-09 | S sold | -2,064 | $91.59 | 0 | D |
| Common Stock | 2026-11-10 | M exercised | +1,301 | $21.77 | 1,301 | D |
| Common Stock | 2026-11-10 | M exercised | +1,260 | $22.07 | 2,561 | D |
| Common Stock | 2026-11-10 | S sold | -2,561 | $90.14 | 0 | D |
| Common Stock | 2026-11-11 | M exercised | +1,744 | $21.77 | 1,744 | D |
| Common Stock | 2026-11-11 | M exercised | +1,300 | $22.07 | 3,044 | D |
| Common Stock | 2026-11-11 | S sold | -3,044 | $90.03 | 0 | D |
| Common Stock | 2026-11-12 | M exercised | +1,339 | $21.77 | 1,339 | D |
| Common Stock | 2026-11-12 | M exercised | +16,385 | $22.07 | 17,724 | D |
| Common Stock | 2026-11-12 | S sold | -17,724 | $90.56 | 0 | D |
| Stock Option (Right to Buy) derivative | 2026-11-09 | M exercised | -29,276 | $0 | 42,500 | D |
| Stock Option (Right to Buy) derivative | 2026-11-09 | M exercised | -20,608 | $0 | 48,143 | D |
| Stock Option (Right to Buy) derivative | 2026-11-09 | M exercised | -40,430 | $0 | 109,570 | D |
| Stock Option (Right to Buy) derivative | 2026-11-09 | M exercised | -10,399 | $0 | 0 | D |
| Stock Option (Right to Buy) derivative | 2026-11-10 | M exercised | -1,301 | $0 | 46,842 | D |
| Stock Option (Right to Buy) derivative | 2026-11-10 | M exercised | -1,260 | $0 | 108,310 | D |
| Stock Option (Right to Buy) derivative | 2026-11-11 | M exercised | -1,744 | $0 | 45,098 | D |
| Stock Option (Right to Buy) derivative | 2026-11-11 | M exercised | -1,300 | $0 | 107,010 | D |
| Stock Option (Right to Buy) derivative | 2026-11-12 | M exercised | -1,339 | $0 | 43,759 | D |
| Stock Option (Right to Buy) derivative | 2026-11-12 | M exercised | -16,385 | $0 | 90,625 | D |